BONNIE RENFRO: Open Payments
NPI 1316722986 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 68 payments from 22 companies in 2025. Trend: 2023 $195 · 2024 $3,494 · 2025 $1,687
Food & beverage: $1,687
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $256 |
| UCB, Inc. | 11 | $186 |
| Lundbeck LLC | 3 | $161 |
| ACADIA Pharmaceuticals Inc | 6 | $147 |
| Axsome Therapeutics, Inc. | 2 | $140 |
| Neurocrine BioSciences, Inc. | 6 | $122 |
| PFIZER INC. | 5 | $99 |
| Eisai Inc. | 3 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $76 |
| Neurelis, Inc. | 3 | $72 |
Products named: VYEPTI, NUPLAZID, Symbravo, UBRELVY, INGREZZA, Fintepla, Leqembi, AJOVY.
Industry payments across OK — which companies pay providers there.
